François Meurice

3.4k total citations · 3 hit papers
25 papers, 2.5k citations indexed

About

François Meurice is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, François Meurice has authored 25 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 11 papers in Infectious Diseases and 7 papers in Health. Recurrent topics in François Meurice's work include Vaccine Coverage and Hesitancy (7 papers), Viral gastroenteritis research and epidemiology (6 papers) and Hepatitis Viruses Studies and Epidemiology (6 papers). François Meurice is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), Viral gastroenteritis research and epidemiology (6 papers) and Hepatitis Viruses Studies and Epidemiology (6 papers). François Meurice collaborates with scholars based in Belgium, United States and United Kingdom. François Meurice's co-authors include S Glismann, Pauline Paterson, Susan L. Rosenthal, Heidi J. Larson, Lawrence R. Stanberry, Olumuyiwa O. Odusanya, Vincent I. Ahonkhai, Robert T. Schoen, Erol Fikrig and Alain Bouckenooghe and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

François Meurice

25 papers receiving 2.3k citations

Hit Papers

Vaccine hesitancy and healthca... 1998 2026 2007 2016 2016 2007 1998 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vaccine hesitancy and healthcare providers
    2016 600 citations Pauline Paterson, François Meurice et al. Vaccine profile →
  2. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
    2007 510 citations François Meurice et al. profile →
  3. Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
    1998 509 citations François Meurice, Erol Fikrig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Meurice Belgium 20 1.4k 914 828 523 432 25 2.5k
Melinda Wharton United States 30 1.4k 1.0× 689 0.8× 2.4k 2.9× 314 0.6× 389 0.9× 67 4.0k
Helen Quinn Australia 33 658 0.5× 849 0.9× 1.8k 2.2× 302 0.6× 232 0.5× 106 3.0k
Barbara J. Kuter United States 31 1.1k 0.8× 709 0.8× 3.0k 3.6× 372 0.7× 1.1k 2.6× 99 3.9k
Marietta Vázquez United States 23 710 0.5× 313 0.3× 2.0k 2.4× 344 0.7× 213 0.5× 37 2.6k
Philip LaRussa United States 35 1.1k 0.8× 298 0.3× 2.8k 3.4× 593 1.1× 257 0.6× 123 3.9k
Adriana Lopez United States 28 633 0.4× 260 0.3× 1.4k 1.7× 1.0k 2.0× 244 0.6× 71 2.6k
Heather F. Gidding Australia 30 694 0.5× 567 0.6× 1.8k 2.1× 304 0.6× 534 1.2× 131 2.7k
Mona Marin United States 29 715 0.5× 762 0.8× 3.1k 3.8× 740 1.4× 528 1.2× 93 3.5k
Todd F. Hatchette Canada 31 1.3k 0.9× 143 0.2× 1.2k 1.5× 465 0.9× 146 0.3× 139 2.7k
Malla Rao United States 41 1.8k 1.2× 327 0.4× 950 1.1× 86 0.2× 699 1.6× 77 3.9k

Countries citing papers authored by François Meurice

Since Specialization
Citations

This map shows the geographic impact of François Meurice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Meurice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Meurice more than expected).

Fields of papers citing papers by François Meurice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Meurice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Meurice. The network helps show where François Meurice may publish in the future.

Co-authorship network of co-authors of François Meurice

This figure shows the co-authorship network connecting the top 25 collaborators of François Meurice. A scholar is included among the top collaborators of François Meurice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Meurice. François Meurice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahonkhai, Aima A., Olumuyiwa O. Odusanya, François Meurice, et al.. (2021). Lessons for strengthening childhood immunization in low- and middle-income countries from a successful public-private partnership in rural Nigeria. International Health. 14(6). 632–638. 4 indexed citations
2.
Heffernan, Catherine, et al.. (2021). Measles, mumps, rubella prevention: how can we do better?. Expert Review of Vaccines. 20(7). 811–826. 22 indexed citations
3.
Paterson, Pauline, François Meurice, Lawrence R. Stanberry, et al.. (2016). Vaccine hesitancy and healthcare providers. Vaccine. 34(52). 6700–6706. 600 indexed citations breakdown →
4.
Hardt, Karin, Ruprecht Schmidt‐Ott, S Glismann, Richard A. Adegbola, & François Meurice. (2013). Sustaining Vaccine Confidence in the 21st Century. SHILAP Revista de lepidopterología. 1(3). 204–224. 29 indexed citations
5.
Odusanya, Olumuyiwa O., et al.. (2011). Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria. Human Vaccines. 7(6). 625–629. 19 indexed citations
6.
Kreth, Hans Wolfgang, et al.. (2008). Sixteen Years of Global Experience with the First Refrigerator-Stable Varicella Vaccine (Varilrix™). BioDrugs. 22(6). 387–402. 26 indexed citations
7.
Odusanya, Olumuyiwa O., et al.. (2008). Determinants of vaccination coverage in rural Nigeria. BMC Public Health. 8(1). 381–381. 240 indexed citations
8.
9.
Odusanya, Olumuyiwa O., François Meurice, & Bernard Hoet. (2006). Nigerian medical students are at risk for hepatitis B infection. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(5). 465–468. 21 indexed citations
10.
Odusanya, Olumuyiwa O., et al.. (2005). Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. International Journal of Infectious Diseases. 9(3). 139–143. 28 indexed citations
11.
Vos, Béatrice De, A. Delem, Karin Hardt, et al.. (2005). A short report on clinical evaluation of RIX4414: highlights of world-wide development. Vaccine. 24(18). 3777–3778. 9 indexed citations
12.
13.
Odusanya, Olumuyiwa O., et al.. (2003). Short term evaluation of a rural immunization program in Nigeria.. PubMed. 95(2). 175–9. 19 indexed citations
14.
15.
Wielen, Marie Van der, et al.. (2000). A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults. Vaccine. 18(20). 2075–2082. 65 indexed citations
16.
LaRussa, Philip, Sharon Steinberg, François Meurice, & Anne A. Gershon. (1997). Transmission of Vaccine Strain Varicella‐Zoster Virus from a Healthy Adult with Vaccine‐Associated Rash to Susceptible Household Contacts. The Journal of Infectious Diseases. 176(4). 1072–1075. 57 indexed citations
17.
Connett, Gary, et al.. (1996). Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children. European Journal of Pediatrics. 155(8). 706–711. 25 indexed citations
18.
Schoen, Robert T., François Meurice, C. Brunet, et al.. (1995). Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease. The Journal of Infectious Diseases. 172(5). 1324–1329. 43 indexed citations
19.
Pépin, Jean‐Louis, et al.. (1992). High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene. 86(3). 254–256. 46 indexed citations
20.
Pépin, Jean‐Louis, et al.. (1989). An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene. 83(4). 514–517. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melinda Wharton Breakdown of academic impact, for papers by Helen Quinn Breakdown of academic impact, for papers by Barbara J. Kuter Breakdown of academic impact, for papers by Marietta Vázquez Breakdown of academic impact, for papers by Philip LaRussa Breakdown of academic impact, for papers by Adriana Lopez Breakdown of academic impact, for papers by Heather F. Gidding Breakdown of academic impact, for papers by Mona Marin Breakdown of academic impact, for papers by Todd F. Hatchette Breakdown of academic impact, for papers by Malla Rao
Rankless by CCL
2026